Placebo for Tofacitinib (CP-690 clinical trials

Tofacitinib in early active axial spondyloarthritis: a prospective, randomized, double-blind, placebo-controlled multicentre study - FASTLANE

This study, called FASTLANE, is looking at a medicine called tofacitinib for early active ankylosing spondylitis. Researchers want to see if it helps reduce disease activity and symptoms. It compares tofacitinib with a dummy pill and a common painkiller.